Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

STF 083010, Tocris Bioscience™

Click to view available options
Quantity:
10mg
50mg
This item is not returnable. View return policy
307543-71-1
C15H11NO3S2
317.377
AUXKGDNZANYAPX-RAXLEYEMSA-N
regid_for_cid_6537512,stf hplc,n-2-hydroxy-1-naphthyl methylene-2-thiophenesulfonamide,e-n-2-hydroxynaphthalen-1-yl methylene thiophene-2-sulfonamide,n-z-2-oxonaphthalen-1-ylidene methyl thiophene-2-sulfonamide
6537512
N-[(Z)-(2-oxonaphthalen-1-ylidene)methyl]thiophene-2-sulfonamide
C1=CC=C2C(=C1)C=CC(=O)C2=CNS(=O)(=O)C3=CC=CS3
This item is not returnable. View return policy
307543-71-1
C15H11NO3S2
317.377
AUXKGDNZANYAPX-RAXLEYEMSA-N
regid_for_cid_6537512,stf hplc,n-2-hydroxy-1-naphthyl methylene-2-thiophenesulfonamide,e-n-2-hydroxynaphthalen-1-yl methylene thiophene-2-sulfonamide,n-z-2-oxonaphthalen-1-ylidene methyl thiophene-2-sulfonamide
6537512
N-[(Z)-(2-oxonaphthalen-1-ylidene)methyl]thiophene-2-sulfonamide
C1=CC=C2C(=C1)C=CC(=O)C2=CNS(=O)(=O)C3=CC=CS3

Inhibits IRE1α endonuclease activity

Inhibitor of IRE1α endonuclease activity; blocks endogenous XBP1 mRNA splicing. Displays cytostatic and cytotoxic effects in CD138+ multiple myeloma (MM) cells in vitro; inhibits bortezomib-induced XBP1 activity in myeloma xenografts in vivo. Does not alter IRE1α kinase activity.
Quantity 10mg
Formula Weight 317.38
Percent Purity >98%
Chemical Name or Material STF 083010

Recommended Storage : Store at -20°C